Condensed Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	IPO	Series A Convertible Preferred Stock	Common Stock	Common Stock IPO	Additional Paid-In Capital	Additional Paid-In Capital IPO	Accumulated Other Comprehensive Gain (Loss)	Accumulated Deficit
Balance at Dec. 31, 2020			$ 55,738
Balance (in shares) at Dec. 31, 2020			7,064,925
Balance at Dec. 31, 2020	$ 5,169			$ 1		$ 13,343			$ (8,175)
Balance (in shares) at Dec. 31, 2020				11,953,107
Series A financing costs			$ (3)
Issuance of restricted stock (in shares)				51,526
Stock-based compensation expense	919					919
Unrealized gain (loss) on investments	(15)							$ (15)
Net loss	(5,852)								(5,852)
Balance at Mar. 31, 2021	221			$ 1		14,262		(15)	(14,027)
Balance (in shares) at Mar. 31, 2021			7,064,925
Balance at Mar. 31, 2021			$ 55,735
Balance (in shares) at Mar. 31, 2021				12,004,633
Balance at Dec. 31, 2020			$ 55,738
Balance (in shares) at Dec. 31, 2020			7,064,925
Balance at Dec. 31, 2020	5,169			$ 1		13,343			(8,175)
Balance (in shares) at Dec. 31, 2020				11,953,107
Issuance of common stock		$ 152,754
Unrealized gain (loss) on investments	2
Net loss	(14,251)
Balance at Jun. 30, 2021	202,016			$ 3		224,437		2	(22,426)
Balance (in shares) at Jun. 30, 2021				28,990,180
Balance at Mar. 31, 2021			$ 55,735
Balance (in shares) at Mar. 31, 2021			7,064,925
Balance at Mar. 31, 2021	221			$ 1		14,262		(15)	(14,027)
Balance (in shares) at Mar. 31, 2021				12,004,633
Exercise of stock options	225					225
Exercise of stock options, (in shares)				43,850
Issuance of common stock					$ 1		$ 152,753
Issuance of common stock (in shares)					9,823,532
Issuance of restricted stock (in shares)				53,240
Stock-based compensation expense	1,463					1,463
Conversion of preferred stock to common stock (In Shares)			(7,064,925)
Conversion of preferred stock to common stock			$ (55,735)
Conversion of preferred stock to common stock (In shares)				7,064,925
Conversion of preferred stock to common stock	55,735			$ 1		55,734
Unrealized gain (loss) on investments	17							17
Net loss	(8,399)								(8,399)
Balance at Jun. 30, 2021	202,016			$ 3		224,437		2	(22,426)
Balance (in shares) at Jun. 30, 2021				28,990,180
Balance at Dec. 31, 2021	178,783			$ 3		228,532		(10)	(49,742)
Balance (in shares) at Dec. 31, 2021				29,115,421
Exercise of stock options	31					31
Exercise of stock options, (in shares)				6,044
Issuance of restricted stock (in shares)				47,216
Stock-based compensation expense	2,330					2,330
Unrealized gain (loss) on investments	(13)							(13)
Net loss	(16,366)								(16,366)
Balance at Mar. 31, 2022	164,765			$ 3		230,893		(23)	(66,108)
Balance (in shares) at Mar. 31, 2022				29,168,681
Balance at Dec. 31, 2021	$ 178,783			$ 3		228,532		(10)	(49,742)
Balance (in shares) at Dec. 31, 2021				29,115,421
Exercise of stock options, (in shares)	15,410
Unrealized gain (loss) on investments	$ (7)
Net loss	(33,624)
Balance at Jun. 30, 2022	150,390			$ 3		233,770		(17)	(83,366)
Balance (in shares) at Jun. 30, 2022				29,280,131
Balance at Mar. 31, 2022	164,765			$ 3		230,893		(23)	(66,108)
Balance (in shares) at Mar. 31, 2022				29,168,681
Exercise of stock options	62					62
Exercise of stock options, (in shares)				9,366
Issuance of restricted stock (in shares)				47,216
Purchases under employee stock purchase plan	256					256
Purchases under employee stock purchase plan (in shares)				54,868
Stock-based compensation expense	2,559					2,559
Unrealized gain (loss) on investments	6							6
Net loss	(17,258)								(17,258)
Balance at Jun. 30, 2022	$ 150,390			$ 3		$ 233,770		$ (17)	$ (83,366)
Balance (in shares) at Jun. 30, 2022				29,280,131